Biotech Stocks To Watch As An Effective Alzheimer’s Treatment Remains Elusive

“Alzheimer’s is the holy grail right now in neurology and diseases of the central nervous system (CNS) because as a form of rapid, non-normal dementia, it is considered especially pernicious as it progresses so quickly in destroying memory,” states the author of today’s article. With that, and with the fact that no effective treatment for the disease currently exists, they highlight a number of biotech stocks to watch with potential Alzheimer’s related developments. For more, CLICK HERE.